ArticleBJU international2019

Impact of 5α-reductase inhibitor and α-blocker therapy for benign prostatic hyperplasia on prostate cancer incidence and mortality.

Maria I Van Rompay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.